electron
microscopi
detect
enter
virus
diarrheic
calv
led
discoveri
number
new
virus
within
past
decad
wherea
rotavirus
coronavirus
primari
enter
pathogen
frequent
associ
neonat
calf
diarrhea
ncd
syndrom
etiolog
role
recent
identifi
virus
ncd
syndrom
undefin
inabl
cultiv
often
fastidi
new
virus
tissu
cultur
preclud
develop
mani
commonli
use
serolog
test
detect
agent
antibodi
knowledg
pathogenesi
epidemiolog
mechan
immun
enter
virus
import
develop
ration
approach
immun
control
viral
diarrhea
infect
commonli
occur
enzoot
calv
wk
age
enhanc
passiv
immun
may
effect
approach
control
passiv
immun
enter
virus
rotavirus
coronavirus
associ
ingest
colostrum
milk
contain
high
concentr
specif
antibodi
lactogen
immun
antibodi
blood
serum
gener
appear
less
valu
protect
virus
review
describ
current
known
diarrheagen
virus
calv
includ
epidemiolog
pathogen
pathogenesi
also
focus
passiv
lactogen
immun
includ
way
enhanc
immun
immun
pregnant
cow
analysi
passiv
protect
calv
fed
variou
colostrum
supplement
report
tabl
descript
current
known
bovin
enter
diarrheagen
virus
half
virus
identifi
within
last
yr
limit
inform
avail
antigen
pathogen
epidemiolog
illustr
tabl
one
serotyp
virus
report
except
rotaviru
possibl
bredaviru
caliciviru
least
two
bovin
rotaviru
serotyp
distinguish
crossprotect
studi
viru
neutral
test
base
presenc
type
specif
antigen
thought
primarili
associ
viral
outer
capsid
layer
howev
rotavirus
speci
also
share
common
groupspecif
antigen
detect
complement
fixat
immunofluoresc
enzymelink
immunosorb
assay
elisa
serolog
test
rotavirus
one
speci
experiment
crossinfect
caus
clinic
diseas
anoth
speci
potenti
may
exist
cattl
infect
rotavirus
origin
speci
bovin
rotaviruslik
agent
rvla
identifi
laboratori
morpholog
ident
rotaviru
differ
antigen
doublestrand
ribonucl
acid
electropherotyp
howev
rvla
react
antigen
similar
rna
electropherotyp
differ
rvla
previous
identifi
pig
suggest
exist
sever
antigen
distinct
categori
rvla
whether
bovin
porcin
rvla
identifi
share
common
antigen
recent
describ
rvla
speci
unknown
bovin
coronaviru
crossreact
antigen
enter
coronavirus
transmiss
gastroenter
tge
viru
swine
canin
coronaviru
felin
infecti
periton
viru
howev
antigen
relat
hemagglutin
encephalomyel
swine
human
respiratori
coronaviru
two
report
suggest
possibl
transmiss
coronavirus
calv
man
epidem
signific
possibl
crossspeci
infect
uncertain
bovin
parvoviru
crossreact
enter
parvovirus
speci
antigen
relationship
newli
describ
virus
similar
virus
differ
speci
gener
undefin
tabl
serolog
test
develop
character
newli
describ
virus
addit
serotyp
may
detect
antigen
relationship
reveal
epidemiolog
pathogen
number
virus
origin
isol
fece
intestin
content
calv
caus
diarrhea
experiment
inocul
gnotobiot
colostrumdepriv
calv
tabl
sever
virus
associ
consist
diarrhea
patholog
intestin
lesion
studi
convent
calv
enterovirus
reovirus
tabl
frequent
detect
calf
fece
report
caus
diarrhea
analog
similar
virus
speci
two
virus
presum
replic
intestin
lymphoid
tissu
may
explain
failur
caus
diarrhea
virus
capabl
caus
diarrhea
replic
either
villou
crypt
intestin
epitheli
cell
tabl
cell
tropism
virus
discuss
later
section
age
incid
infect
calv
report
variou
virus
enter
diseas
agent
tabl
virus
tabl
endem
adult
cattl
seroposit
antibodi
rotaviru
coronaviru
parvoviru
cattl
neutral
antibodi
bovin
viral
diarrhea
viru
bvd
none
recent
describ
virus
bredaviru
rvla
caliciviru
asroviru
passag
serial
cell
cultur
preclud
use
routin
serolog
test
assay
presenc
antibodi
agent
thu
preval
unknown
ubiquit
stabl
natur
enter
virus
result
infect
calv
protect
umbrella
passiv
antibodi
may
explain
gener
high
morbid
low
mortal
associ
infect
mark
contrast
epidem
swine
coronaviru
tge
caus
high
mortal
seronegar
piglet
less
wk
age
widespread
occurr
antibodi
enter
virus
bovin
colostrum
may
explain
partial
age
incid
rotaviru
coronaviru
e
parvoviru
infect
occur
time
day
age
titer
passiv
milk
antibodi
decreas
unprotect
concentr
infect
younger
calv
day
virus
may
relat
low
colostr
antibodi
titer
higher
dose
viru
failur
transfer
passiv
immun
exist
anim
seroneg
bvd
viru
occasion
coronaviru
explain
abil
virus
infect
anim
variou
age
includ
adult
depend
serolog
statu
bovin
viral
diarrhea
viru
may
occur
young
calv
day
old
result
late
gestat
utero
infect
seroneg
dam
enter
diarrheagen
virus
may
categor
accord
site
replic
vertic
longitudin
within
intestin
tract
first
type
viru
type
tabl
infect
villou
epitheli
cell
usual
caus
system
infect
includ
coronaviru
rotaviru
newli
describ
virus
contrast
virus
second
type
infect
primarili
crypt
enterocyt
intestin
lymphoid
cell
usual
caus
system
infect
type
virus
present
includ
parvoviru
bvd
viru
tabl
type
virus
thought
transmit
fecalor
rout
result
direct
infect
villou
epitheli
cell
via
lumin
surfac
cell
whether
certain
virus
also
transmit
aerosol
exposur
viru
initi
replic
oropharynx
lead
massiv
dose
virus
swallow
unclear
need
investig
preliminari
studi
laboratori
experiment
oralintranas
exposur
colostrumdepriv
gnotobiot
calv
bovin
coronaviru
led
coronaviru
antigen
small
intestin
colon
also
tracheal
nasal
smear
prepar
day
postexposur
dpe
l
j
sail
r
redman
k
w
theil
unpublish
observ
replic
coronaviru
tge
also
occur
tissu
upper
respiratori
tract
find
suggest
possibl
labil
envelop
enter
virus
coronaviru
may
undergo
initi
replic
oropharynx
contribut
massiv
dose
viru
small
intestin
viremia
gener
report
type
virus
definit
explan
account
villou
epitheli
cell
tropism
type
virtrs
possibl
explan
includ
role
cell
receptor
variou
enzym
within
brush
border
enzymat
matur
villou
epitheli
cell
enzym
may
requir
viral
uncoat
exposur
cell
receptor
manner
similar
vitro
requir
intestin
enzym
trypsin
chymotrysin
pancreatin
replic
rotavirus
human
astroviru
cell
cultur
addit
neonat
virus
might
taken
absorpt
villou
epitheli
cell
nonspecif
via
pinocytosi
period
colostrum
absorpt
type
virus
infect
destroy
villou
epitheli
cell
result
villou
atrophi
loss
matur
absorpt
ceil
lead
malabsorpt
diarrheal
syndrom
typic
viral
infect
review
diarrheal
pathogenesi
moon
drew
corollari
sever
variou
viral
infect
extent
viral
replic
epitheli
cell
line
side
tip
villi
wherea
rotaviru
mainli
infect
cell
apic
half
villi
enzymat
matur
cell
produc
milder
transient
diarrhea
coronavirus
infect
epitheli
cell
throughout
length
villi
caus
pronounc
villou
atrophi
also
diarrhea
epitheli
cell
villi
tip
constantli
replac
cell
prolifer
crypt
migrat
side
villi
turnov
rate
ceil
slower
younger
gnotobiot
anim
lead
less
rapid
repair
villou
atrophi
may
contribut
enhanc
suscept
neonat
viral
diarrhea
increas
frequenc
villou
epitheli
cell
replac
loss
capac
absorb
macromolecul
ig
colostrum
agerel
factor
may
increas
resist
older
anim
viral
diarrhea
loss
absorpt
capac
may
reduc
anim
suscept
enter
viral
infect
elimin
possibl
nonspecif
uptak
viral
bacteri
pathogen
via
pinocytot
pathway
ig
absorb
constant
replac
damag
villou
epitheli
cell
cell
origin
crypt
refractori
rotaviru
infect
suggest
anim
infect
selflimit
howev
caus
concern
might
multipl
infect
occur
natur
sever
type
type
virus
destroy
villou
crypt
enterocyt
infect
presum
could
lead
much
greater
morbid
mortal
one
agent
alon
one
studi
mortal
rate
increas
number
enter
virus
detect
experiment
studi
pathogenesi
possibl
addit
synergist
interact
multipl
viral
infect
calv
detect
sever
virus
singl
diarrheic
calf
common
besid
share
intestin
cell
tropism
type
virus
also
possess
common
physicochem
biolog
characterist
describ
tabl
properti
stabil
low
ph
proteolyt
enzym
enabl
virus
function
well
intestin
environ
inabl
propag
mani
fastidi
enter
virus
cell
cultur
electron
microscopi
instrument
detect
identif
virus
second
type
infect
mainli
crypt
epitheli
intestin
lymphoid
cell
tabl
also
thought
transmit
via
fecalor
respiratori
rout
predilect
bvd
parvoviru
crypt
epitheli
intestin
lymphoid
cell
probabl
relat
rapid
prolif
rate
cell
vivo
replic
virus
requir
popul
cell
undergo
frequent
mitosi
discuss
moon
infect
crypt
epitheli
cell
type
virus
also
lead
sever
villou
atrophi
loss
crypt
consequ
replac
villou
epitheli
cell
result
state
total
mucos
collaps
besid
vertic
stratif
viru
replic
site
within
intestin
epitheli
ceil
also
appear
longitudin
differenti
viral
replic
site
intestin
tabl
gener
virus
replic
limit
portion
intestin
infect
scatter
epitheli
cell
caus
mild
villou
atrophi
subsequ
mild
diarrhea
comparison
virus
replic
throughout
entir
intestin
infect
high
percentag
epitheli
cell
might
expect
caus
sever
villou
atrophi
diarrhea
exampl
viru
astroviru
produc
patchi
fluoresc
indic
scatter
infect
cell
calf
limit
replic
result
littl
villou
atrophi
diarrhea
tabl
coronaviru
howev
produc
almost
continu
infect
entir
villou
enterocyt
throughout
distal
portion
small
intestin
colon
usual
associ
sever
diarrheal
syndrom
experiment
inocul
natur
infect
calv
bovin
bredaviru
similar
predilect
cell
distal
portion
small
intestin
colon
gener
produc
milder
diarrheal
syndrom
rotaviru
rvla
gener
replic
caus
villou
atrophi
distal
half
small
intestin
colon
wherea
bovin
caliciviru
replic
produc
villou
atrophi
proxim
portion
small
intestin
tabl
cell
tropism
reason
predilect
differ
virus
certain
region
intestin
unclear
physiolog
factor
differ
enzym
concentr
ph
presenc
bile
salt
may
play
role
studi
shown
longitudin
differenti
small
intestin
regard
absorpt
nutrient
cell
turnov
activ
increas
duodenum
variabl
may
influenc
viru
stabil
receptor
replic
immunolog
factor
region
variat
concentr
local
antibodi
cellmedi
immun
interferon
also
may
influenc
intestin
viral
replic
site
numer
detail
review
rumin
humor
immun
system
summar
briefli
predomin
bovin
serum
occur
similar
concentr
iggx
major
isotyp
bovin
mammari
secret
transport
activ
serum
colostrum
also
milk
although
less
preval
milk
uniqu
rumin
iga
predomin
mammari
secret
monogastr
includ
human
monogastr
speci
secretori
iga
siga
antibodi
occur
milk
antigen
stimul
gastrointestin
tract
dam
follow
enter
infect
parenter
immun
gener
elicit
igg
milk
antibodi
follow
local
intestin
antigen
stimul
iga
immunocyt
migrat
gut
mammari
gland
secret
siga
antibodi
milk
thu
establish
enteromammari
siga
ink
thu
antibodi
specificit
milk
iga
reflect
antigen
challeng
intestin
tract
dam
studi
address
question
similar
enteromammari
siga
link
bovin
antigen
stimul
oral
rout
would
elicit
iga
milk
antibodi
one
studi
oral
vaccin
pregnant
cow
live
dead
escherichia
coli
pilu
type
result
littl
antibodi
respons
serum
colostrum
antibodi
respons
milk
howev
subsequ
parenter
booster
immun
cow
lactat
result
blood
serum
low
milk
antibodi
respons
higher
live
e
coli
vaccin
cow
ig
isotyp
e
coli
antibodi
determin
anoth
studi
jejun
infus
pregnant
cow
nonrepl
bacteriophag
antigen
elicit
iga
antibodi
serum
mammari
secret
found
similar
result
preliminari
studi
oral
administr
live
virul
bovin
rotaviru
five
pregnant
rotaviru
seroposit
cow
iggl
rotaviru
antibodi
elev
mammari
secret
two
five
cow
l
j
sail
k
l
smith
r
redman
unpublish
observ
sourc
elev
oolostr
milk
antibodi
two
studi
unclear
former
studi
demonstr
iggi
produc
cell
mammari
secret
spite
predomin
respons
possibl
explan
might
plasma
cell
occur
rel
larg
number
intestin
adult
rumin
contribut
antibodi
specif
enter
antigen
serum
transport
activ
colostrum
milk
also
would
explain
occurr
predomin
lggt
rotaviru
coronaviru
antibodi
mammari
secret
natur
infect
presum
via
oral
rout
cow
figur
tabl
similar
mechan
recent
propos
select
transport
dimer
serum
lga
produc
intestin
iga
plasma
cell
colostrum
lactat
mice
preliminari
find
suggest
enter
prime
boost
may
effect
mean
elicit
siga
antibodi
bovin
mammari
secret
inde
bovin
mammari
gland
gener
describ
defici
iga
may
relat
rumen
develop
although
sever
studi
indic
bovin
iga
milk
antibodi
produc
local
intramammari
imm
infus
antigen
origin
cell
produc
iga
undefin
follow
discuss
attent
direct
primarili
toward
passiv
immun
type
virus
viral
infect
passiv
immun
conting
upon
continu
adequ
amount
antibodi
gut
lumen
protect
villou
enterocyt
serumderiv
antibodi
gener
play
minor
role
usual
littl
correl
serum
antibodi
infect
revers
situat
type
virus
studi
bvd
canin
parvovir
infect
posit
correl
viru
neutral
antibodi
titer
blood
serum
activ
passiv
acquir
protect
infect
presum
viru
infect
intestin
ceil
via
hematogen
rout
therefor
neutral
viru
reach
suscept
intestin
ceil
may
key
factor
immun
type
viral
infect
bovin
rotaviru
coronaviru
two
wellcharacter
enter
virai
infect
serv
use
model
studi
passiv
immun
type
virus
studi
laboratori
other
use
isotyp
specif
elisa
viru
neutral
vn
test
confirm
predomin
iggz
rotaviru
coronaviru
antibodi
mammari
secret
natur
infect
seroposit
cow
figur
tabl
follow
preval
iga
antibodi
figur
colostr
rotaviru
antibodi
titer
decreas
precipiti
transit
milk
figur
contrast
monogastr
human
swine
iga
rotaviru
antibodi
predomin
milk
presum
due
enteromammari
siga
link
titer
decreas
dramat
transit
milk
arepres
entir
pool
first
milk
colostrum
five
cow
group
bgmt
geometr
mean
titer
comput
minimum
five
replic
sampl
cbracket
confid
interv
el
transport
select
serum
colostrum
milk
ration
approach
boost
rotaviru
coronaviru
antibodi
bovin
mammari
secret
would
parenter
immun
pregnant
dam
virus
therebi
enhanc
serum
henc
colostr
rotaviru
antibodi
studi
would
requir
evalu
protect
capac
igga
antibodi
calf
viral
challeng
number
variabl
need
consid
attempt
maxim
antibodi
respons
mammari
secret
first
rout
time
immun
figur
extrem
high
colostr
rotaviru
antibodi
titer
achiev
intramuscular
im
immun
wk
prepartum
immun
imm
infus
wk
postim
pregnant
dam
ohio
agricultur
research
develop
center
guard
norden
laboratori
lincoln
ne
oardc
propag
modifiedl
ncdv
bovin
rotaviru
administ
freund
incomplet
adjuv
signific
lower
increas
three
colostr
antibodi
isotyp
well
figur
import
find
antibodi
titer
remain
significantli
elev
milk
compar
control
least
day
postpartum
figur
comparison
im
administr
modifiedl
rotaviru
strain
coronaviru
commerci
vaccin
administ
without
adjuv
wk
prepartum
result
signific
increas
colostr
milk
rotaviru
coronaviru
antibodi
titer
compar
control
figur
tabl
rational
im
imm
schedul
base
hypothesi
peripher
stimulu
im
administ
near
involut
could
result
seed
sensit
cell
mammari
gland
subsequ
imm
present
antigen
might
result
expans
clone
cell
effect
increas
antibodi
mammari
secret
immun
studi
sheep
cattl
demonstr
enhanc
antibodi
respons
isotyp
milk
regimen
although
imm
immun
may
applic
dairi
cow
particularli
dri
period
would
practic
beef
cow
end
studi
report
significantli
enhanc
blood
serum
mammari
secret
rotaviru
antibodi
titer
parenter
rout
includ
im
subcutan
sc
inject
adjuvant
inactiv
virul
adjuvant
inactivat
live
modifi
bovin
rotaviru
howev
rotaviru
antibodi
titer
mammari
secret
great
studi
two
studi
antibodi
fail
protect
nurs
colostrumsuppl
calv
rotaviru
diarrhea
howev
two
studi
report
decreas
rotaviru
incid
durat
sever
daili
feed
rotaviru
immun
colostrum
supplement
dairi
calv
addit
rout
immun
anoth
import
variabl
studi
other
use
adjuvant
vaccin
enhanc
rotaviru
antibodi
mammari
secret
investig
hess
et
al
demonstr
littl
increas
colostr
milk
antibodi
titer
cow
immun
rotaviru
alon
studi
anoth
show
variou
adjuv
differ
abil
enhanc
rotaviru
antibodi
titer
mammari
secret
find
concur
result
incorpor
freund
incomplet
adjuv
commerci
rotacoronaviru
vaccin
led
enhanc
colostr
rotaviru
antibodi
titer
associ
primarili
wherea
use
unadjuvant
vaccin
increas
significantli
colostr
antibodi
titer
compar
control
figur
howev
antibodi
titer
still
lower
adjuvant
commerci
vaccin
oardc
adjuvant
vaccin
im
plu
imm
figur
result
studi
demonstr
use
adjuv
could
boost
nonspecif
antibodi
titer
unrel
viru
seroposit
anim
conclud
other
tabl
administr
adjuvant
oardc
rotaviru
vaccin
enhanc
significantli
coronaviru
colostr
igg
antibodi
titer
group
compar
control
third
variabl
signific
rotaviru
matern
vaccin
procedur
viru
titer
dose
form
live
inactiv
experi
titer
oardc
vaccin
x
lo
pfuml
time
greater
rotaviru
titer
commerci
vaccin
pfuml
differ
titer
also
may
influenc
rotaviru
antibodi
respons
mammari
secret
also
consid
optim
viru
dose
use
inactiv
vaccin
may
necessit
use
higher
titer
viru
larger
amount
achiev
effect
live
attenu
viru
antigen
viral
protein
may
destroy
inactiv
process
effect
differ
inactiv
agent
also
need
analyz
preliminari
studi
found
differ
antibodi
respons
binari
ethylenimin
bei
inactiv
versu
bpropiolacton
bpl
inactiv
bovin
rotaviru
although
agent
success
inactiv
rotaviru
antibodi
titer
time
greater
mammari
secret
cow
vaccin
bei
inactiv
rotaviru
compar
vaccin
bpl
inactiv
rotaviru
newborn
calf
agammaglobulinem
depend
upon
colostr
immunoglobulin
local
intestin
humor
immun
uptak
colostr
ig
across
intestin
epithelium
circul
occur
limit
time
h
birth
passiv
acquir
humor
antibodi
primarili
isotyp
persist
sever
week
protect
newborn
especi
system
infect
circul
antibodi
although
essenti
local
protect
enter
infect
may
moder
sever
durat
infect
high
titer
numer
studi
document
import
almost
continu
presenc
colost
milk
antibodi
lactogen
immun
within
gut
lumen
effect
protect
enter
virus
swine
siga
milk
antibodi
provid
optim
passiv
protect
tge
viru
high
igg
milk
antibodi
also
protect
titer
could
maintain
throughout
lactat
studi
bovin
anim
attempt
correl
antibodi
isotyp
colostrum
milk
passiv
immun
enter
viral
infect
investig
abil
colostrum
supplement
im
plu
imm
oardc
rotaviru
vaccin
immun
cow
unimmun
control
cow
protect
newborn
colostrumdepriv
cd
dairi
calv
experiment
rotaviru
challeng
colostrum
supplement
fed
volvol
concentr
either
timesday
begin
within
h
birth
continu
day
rational
feed
regimen
feed
normal
control
colostrum
rotaviru
challeng
calv
concentr
timesday
protect
rotaviru
diarrhea
shed
wherea
feed
higher
concentr
control
colostrum
provid
partial
immun
rotaviru
antibodi
titer
milk
sampl
cow
declin
initi
colostrum
antibodi
titer
figur
decreas
milk
antibodi
titer
similar
decreas
total
iggl
transit
colostrum
milk
one
group
experiment
calv
receiv
supplement
colostrum
feed
calv
challeng
oral
virul
ncdv
bovin
rotaviru
h
age
monitor
daili
occurr
diarrhea
fecal
rotaviru
shed
elisa
stool
character
abnorm
base
color
yellow
bright
green
consist
semiliquid
liquid
result
calf
challeng
studi
summar
tabl
figur
colostrumdepriv
calv
fed
supplement
colostrum
rotaviru
serum
antibodi
titer
challeng
calv
develop
rotavirusassoci
diarrhea
dpe
abnorm
stool
persist
dpe
rotaviru
shed
detect
averag
dpe
typic
serum
fecal
antibodi
respons
cd
calf
cd
illustr
figur
isotyp
specif
elisa
rotaviru
antibodi
serum
follow
infect
associ
primarili
igm
iga
earli
respons
dpe
antibodi
undetect
dpe
serum
antibodi
iggx
also
detect
dpe
preval
dpe
serum
antibodi
detect
dpe
titer
increas
second
dpe
viru
neutral
rotaviru
antibodi
detect
dpe
titer
consist
lower
elisa
titer
transient
fecal
igm
iga
antibodi
respons
occur
dpe
detect
even
continu
shed
viral
antigen
dpe
fecal
igg
antibodi
detect
throughout
dpe
sampl
period
result
correl
studi
rotaviru
infect
children
specificpathogenfre
pig
demonstr
transient
fecal
iga
igm
antibodi
respons
investig
studi
rotaviru
tge
swine
report
primarili
lgg
transient
iga
respons
convalesc
serum
follow
intestin
infect
serum
iga
respons
mostli
dimer
iga
swine
cattl
may
repres
transfer
intestin
sythes
iga
antibodi
serum
rapid
disappear
serum
iga
antibodi
may
relat
report
select
transfer
dimer
serum
iga
secretori
site
back
intestin
via
bile
supplement
feed
colostrum
control
cow
protect
newborn
calv
challeng
rotaviru
either
rotaviru
associ
diarrhea
shed
tabl
figur
blood
serum
fecal
rotaviru
antibodi
respons
calv
fed
supplement
control
colostrum
similar
calv
fed
supplement
colostrum
figur
cd
calf
princip
differ
low
igg
serum
antibodi
time
challeng
h
age
two
control
colostrum
feed
calv
fed
colostrum
supplement
cow
immun
commerci
vaccin
similar
respons
fed
control
colostrum
data
shown
rotaviru
serum
geometr
mean
titer
gmt
similar
challeng
calv
fed
control
commerci
vaccin
colostrum
rang
reflect
similar
initi
antibodi
titer
two
colostrum
pool
figur
howev
calv
fed
two
colostrum
pool
slightli
delay
onset
shorter
durat
viru
shed
diarrhea
compar
calv
fed
colostrum
figur
tabl
suggest
even
low
colostr
rotaviru
antibodi
may
provid
slight
passiv
immun
rotaviru
infect
snodgrass
well
report
similar
find
lamb
fed
serum
low
antibodi
titer
protect
challeng
compar
lamb
fed
serum
devoid
rotaviru
antibodi
feed
calv
pool
colostrum
supplement
im
plu
imm
oardc
vaccin
immun
cow
confer
clinic
protect
prevent
rotaviru
shed
tabl
two
three
calv
remain
clinic
normal
fail
excret
rotaviru
follow
second
homolog
challeng
wk
age
indic
probabl
initi
develop
subclin
infect
subsequ
activ
immun
figur
activ
immun
indic
transient
increas
blood
serum
iga
igm
antibodi
follow
viru
challeng
observ
similar
studi
passiv
immun
rotaviruschalleng
gnotobiot
lamb
fed
homolog
colostrum
gnotobiot
piglet
fed
bovin
colostrum
illustr
figur
cd
calf
calv
high
serum
viru
neutral
antibodi
titer
im
plu
imm
oardc
vaccin
colostrum
feed
indic
passiv
absorb
colostr
antibodi
antibodi
declin
throughout
sampl
period
still
detect
time
calv
fed
colostrum
im
plu
imm
cow
high
passiv
rotaviru
antibodi
fece
compar
calv
two
previou
feed
group
titer
decreas
challeng
still
present
day
termin
supplement
colostrum
feed
figur
furthermor
detect
igm
iga
rotaviru
antibodi
fece
titer
challeng
failur
may
relat
suppress
activ
local
intestin
iga
igm
antibodi
passiv
acquir
colostr
develop
low
undetect
titer
iga
igm
fecal
antibodi
respons
subclin
infect
calv
fed
supplement
im
plu
imm
colostrum
delay
onset
shorter
durat
diarrhea
rotaviru
shed
compar
control
tabl
serum
fecal
rotaviru
antibodi
respons
intermedi
im
plu
imm
control
colostrumsuppl
calv
figur
passiv
acquir
rotaviru
antibodi
lower
im
plu
imm
colostrumf
calv
higher
calv
fed
control
colostrum
howev
serum
fecal
iga
igm
antibodi
respons
lower
control
group
calv
fed
colostrum
observ
appear
prolong
diarrhea
viru
shed
correl
greater
iga
igm
fecal
antibodi
respons
find
concur
similar
result
studi
rotaviru
infect
children
number
calv
four
eight
began
shed
rotaviru
spontan
within
day
termin
feed
supplement
colostrum
im
plu
imm
oardc
vaccin
cow
viru
excret
persist
sever
day
accompani
mild
diarrhea
day
similar
sequenc
viru
shed
occur
two
calv
fed
colostrum
im
plu
imm
cow
calf
fed
control
colostrum
howev
two
latter
three
anim
shed
viru
day
colostrum
feed
ceas
observ
rais
question
sourc
rotaviru
infect
possibl
rotaviru
transmit
calv
caretak
exclud
total
howev
anoth
plausibl
explan
may
initi
rotaviru
challeng
anim
develop
limit
subclin
infect
indic
develop
iga
igm
serum
antibodi
infect
kept
abey
daili
colostrum
feed
sometim
result
mild
overt
infect
colostrum
feed
ceas
evid
support
conclus
protect
studi
two
rotaviru
challeng
gnotobiot
piglet
fed
bovin
colostrum
anim
remain
clinic
normal
colostrum
feed
cessat
similar
subclin
excret
viru
commenc
one
piglet
develop
serum
antibodi
result
studi
concur
report
document
import
lactogen
immun
effect
protect
type
enter
virus
cessat
colostrum
feed
led
suscept
diseas
infect
sever
calv
calv
fed
smaller
amount
im
plu
imm
colostrum
lower
titer
colostrum
control
usual
commenc
viru
shed
earlier
colostrum
feed
ceas
anim
fed
high
titer
colostrum
im
plu
imm
cow
result
may
relat
higher
titer
serum
antibodi
latter
group
calv
compar
previou
calv
antibodi
may
transfer
serum
back
intestin
account
persist
fecal
antibodi
termin
colostrum
feed
provid
transient
passiv
protect
studi
document
transport
serum
intestin
sheep
cattl
studi
also
indic
passiv
acquir
serum
rotaviru
antibodi
high
titer
could
protect
rotavirusassoci
diarrhea
lamb
high
serum
ig
concentr
correl
absenc
diarrhea
young
calv
altern
addit
explan
delay
onset
viru
shed
persist
iggl
fecal
antibodi
cessat
colostrum
feed
might
rotaviru
colostr
antibodi
select
bind
enterocyt
similar
colostr
iga
rat
high
titer
antibodi
effect
block
rotaviru
infect
result
studi
possibl
mechan
rotaviru
pafhogenesi
field
condit
suggest
dam
may
shed
rotaviru
near
parturit
thu
serv
sourc
viru
suscept
neonat
infect
neonat
may
occur
birth
shortli
thereaft
infect
remain
subclin
long
adequ
colostr
milk
serum
antibodi
persist
cow
colostr
rotaviru
antibodi
decreas
dramat
transit
milk
coincid
peak
occurr
calf
rotaviru
infect
day
age
agerel
suscept
also
may
influenc
limit
local
protect
provid
revers
transport
higher
titer
calv
receiv
adequ
amount
colostrum
shortli
birth
serum
antibodi
back
intestin
depend
number
poorli
understood
variabl
calv
may
begin
shed
rotaviru
without
accompani
diseas
present
investig
other
indic
wherea
anim
protect
receiv
passiv
immun
may
develop
activ
immun
anim
may
remain
suscept
subsequ
infect
becom
sourc
viru
addit
anim
might
explain
partial
occasion
occurr
sequenti
rotaviru
infect
anim
find
show
correl
colostr
antibodi
titer
amount
colostrurn
fed
passiv
protect
import
implic
passiv
immun
enter
infect
dairi
beef
calv
milk
antibodi
titer
im
plu
imm
oardc
rotaviru
vaccin
immun
cow
repres
approxim
vn
elisa
colostr
antibodi
titer
protect
extrapol
result
suggest
milk
protect
natur
rotaviru
infect
fed
undilut
natur
artifici
suckl
calv
dairi
herd
daili
feed
fresh
frozen
colostrum
supplement
immun
cow
calv
provid
effect
passiv
immun
durat
colostrum
feed
supplement
feed
wk
may
suffici
older
anim
gener
possess
high
agespecif
resist
symptomat
rotaviru
infect
experi
colostrum
high
titer
rotaviru
iggx
antibodi
provid
effect
passiv
immun
rotaviru
challeng
calv
suggest
bovin
igga
iga
may
play
major
role
passiv
mucos
immun
observ
support
concept
includ
predomin
bovin
mammari
secret
specif
bovin
milk
enter
antigen
natur
infect
cow
resist
certain
proteolyt
enzym
typic
characterist
siga
speci
although
colostrum
milk
rotaviru
antibodi
enhanc
follow
matern
immun
sever
studi
result
variabl
passiv
protect
studi
field
condit
explan
equivoc
result
challeng
nurs
immun
cotostrum
supplement
calv
uncertain
influenc
number
variabl
need
consid
includ
experiment
determin
minim
protect
dose
colostrum
milk
necessari
provid
homolog
protect
symptomat
infect
studi
indic
high
titer
necessari
complet
protect
vn
antibodi
titer
colostrum
supplement
initi
vn
titer
colostrum
supplement
initi
vn
titer
second
addit
studi
need
determin
amount
heterolog
crossprotect
provid
challeng
differ
newli
recogn
serotyp
bovin
rotaviru
time
colostrum
feed
versu
challeng
challeng
dose
virul
viru
strain
concurr
infect
may
play
role
suscept
infect
even
control
experiment
condit
